Stay updated on XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial

Sign up to get notified when there's something new on the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T20:41:18.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the expected study record content, indicating an access restriction. The usual navigation and study details are replaced by an error message.
    Difference
    17%
    Check dated 2026-09-20T20:45:25.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Prostate cancer and MedlinePlus Genetics were added as related topics to expand navigation and cross-references for readers.
    Difference
    0.2%
    Check dated 2026-09-13T21:58:55.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page footer's revision string was updated from v3.6.5 to v3.6.6, representing a platform update rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-08-30T22:39:25.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Revision: v3.6.5 was added, indicating a newer version of the ClinicalTrials.gov study record. Several glossary terms, metadata fields, and historical labels were removed, signaling metadata cleanup and reorganization of how the study information is presented.
    Difference
    16%
    Check dated 2026-08-09T09:13:07.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The page now includes a Prostate cancer tag and a MedlinePlus Genetics related topics section. These additions connect the study to its disease context and provide access to related genetic information.
    Difference
    0.2%
    Check dated 2026-08-01T23:16:55.000Z thumbnail image

Stay in the know with updates to XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page.